Arixtra
Arixtra Brand names, Arixtra Analogs
Arixtra Brand Names Mixture
- No information avaliable
Arixtra Chemical_Formula
C31H43N3Na10O49S8
Arixtra RX_link
http://www.rxlist.com/cgi/generic3/arixtra.htm
Arixtra fda sheet
Arixtra msds (material safety sheet)
Arixtra Synthesis Reference
No information avaliable
Arixtra Molecular Weight
1726.77 g/mol
Arixtra Melting Point
No information avaliable
Arixtra H2O Solubility
No information avaliable
Arixtra State
Liquid
Arixtra LogP
No information avaliable
Arixtra Dosage Forms
Solution
Arixtra Indication
For the treatment of prophylaxis of deep vein thrombosis.
Arixtra Pharmacology
Fondaparinux is a synthetic and specific inhibitor of activated Factor X (Xa) indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism. Fondaparinux is also indicated for the treatment of acute deep vein thrombosis when administered in conjunction with warfarin, and the treatment of acute pulmonary embolism when administered in conjunction with warfarin. Fondaparinux does not inactivate thrombin (activated Factor II) and has no known effect on platelet function. At the recommended dose, Fondaparinux does not affect fibrinolytic activity or bleeding time.
Arixtra Absorption
100%
Arixtra side effects and Toxicity
No information avaliable
Arixtra Patient Information
No information avaliable
Arixtra Organisms Affected
Humans and other mammals
